baber/WOPTO huggingface dataset:
Patent NZ-268938-A (NZ)
Title: Epoxy composition comprising an infusible, gelled, curable epoxy resin composition prepared using a hardener which does not cause complete curing of the epoxy resin component
Inventor: WHITE PETER DRUMMOND BOYS
IPC: C08G59/50
Filed: 1994-07-27
Abstract: PCT No. PCT/GB94/01614 Sec. 371 Date Jan. 25, 1996 Sec. 102(e) Date Jan. 25, 1996 PCT Filed Jul. 27, 1994 PCT Pub. No. WO95/04095 PCT Pub. Date Feb. 9, 1995The present invention relates to an epoxy composition that is isolated in the form of an infusible, gelled, heat curable, epoxy functional reaction product. The reaction product is formed by mixing together: (A) one or more epoxy resins or epoxy group containing compounds and (B) a hardener system which will react with (A) to give a gelled solid, but which does not cause complete curing of (A) under the reaction conditions chosen for reaction of (A) and (B) to give a gelled solid. The reaction product can be formed by including (C) an optional further hardener system for (A) and the reaction product of (A) and (B), which is different from (B), and which remains largely unreacted with (A) and (B) under said reaction conditions. The present invention further relates to a cured product of said epoxy composition.
Patent NZ-272244-A (NZ)
Title: Accounting and data collection for a gaming machine
Inventor: LESTRANGE MICHAEL M
IPC: G07F9/08
Filed: 1995-05-30
Abstract: The system includes a credit meter (28) for storing amount of residual game credit purchased corresponding to credit purchased which has not yet been risked by a player. Accounting meters (34) traces game activity within a gaming machine including total wagers accepted and total winnings paid to players of the gaming machine. An event processor (26) senses gaming machine events including amount and form of game credit purchase and amount of a wager by the player. The processor also updates the credit meter when game credit is purchased, when a wager is placed and when credit is collected by the player and increments the accounting meter by the amount of credit collected in excess of the amount of residual credit available to the player.
Patent NZ-312043-A (NZ)
Title: Door jamb assembly, jamb is retractable to allow locked door to be opened from inside in emergency
Inventor: SIDNEY KENNETH JAMES
IPC: E06B1/52
Filed: 1996-07-11
Abstract: A door jamb assembly for a door 13 includes a movable side jamb 14.  The jamb can be moved from a normal position in which a lock bolt 16 in the door lock can engage a striker plate in the jamb, to a second position in which the bolt is free of the striker plate so that the door can be opened.  The jamb 14 moves away from the edge of the door, and may be moved by, for example, cams 23.  Spring loaded pins 19 bias the jamb 14 into the normal position.  The jamb assembly is intended for use in doors that must be openable from one side at all times to allow exit in an emergency.
Patent NZ-319571-A (NZ)
Title: Process for purifying alkoxylated fats
Inventor: DRALLE-VOSS GABRIELE
IPC: A61K47/44
Filed: 1996-09-20
Abstract: process for purifying alkoxylated fats by treatment with a solid substance, characterized in that the solid substance used is a mixture of aluminium oxide and a silicate.  This invention also claims the use of said purified alkoxylated fats in the production of pharmaceutical formulations.
Patent NZ-329630-A (NZ)
Title: Carrier with tear resistant handle with tabs extending from handle legs into top panel apertures
Inventor: HARRELSON GLEN RAY
IPC: B65D67/02
Filed: 1997-08-12
Abstract: A bottle carrier (12) having a suitcase-type handle (44) connected to the top panel (14) by spaced fold line segments (58, 60). The top panel of the carrier includes apertures (96) adjacent the outer ends of the outer fold line segments. Tabs (90) at the outer ends of the handle extend through the apertures (96) into the interior of the carrier, thereby preventing tearing at the handle when lifting and carrying the carrier. The top panel is comprised of partially overlapping top panel sections (54, 56), and a central tab (86) integral with the overlapping top panel section extends through the central opening of the suitcase-type handle.
Patent NZ-331977-A (NZ)
Title: Texaphyrin in photodynamic therapy of pigment-related lesions
Inventor: WOODBURN KATHRYN W
IPC: A61K41/00
Filed: 1997-03-26
Abstract: A photosensitive compound called texaphyrin and shown for the photodynamic treatment of a pigmented lesion, such as a melanodermic lesion, or of a lesion obscured by pigmented tissue, such as melaniferous tissue in a subject. It provides a treatment for the metastatic process of melanoma, and a method for inhibiting growth of established metastases of melanoma. The photosensitive texaphyrin may be a free-base texaphyrin or may be metallated with a diamagnetic metal. Preferably, the texaphyrin is metallated with lutetium. Wherein; M is a diamagnetic metal cation; R1-R4, R7 and R8 are independently hydrogen, halide, hydroxyl, alkyl, alkenyl, alkynyl, aryl, haloalkyl, nitro, formyl, acyl, hydroxyalkyl, alkoxy, hydroxyalkoxy, hydroxyalkenyl, hydroxyalkynyl, saccharide, carboxy, carboxyalkyl, carboxyamide, carboxyamidealkyl, amino, aminoalkyl, a site-directing molecule, a catalytic group, or a couple that is coupled to a site-directing molecule or to a catalytic group; R6 and R9 are independently selected from the groups of R1-R4, R7 and R8, the proviso that the halide is other than iodide and the haloalkyl is other than iodoalkyl; R5 and R10-R12 are independently hydrogen, alkyl, alkenyl, alkynyl, aryl, hydroxyalkyl, alkoxy, hydroxyalkoxy, hydroxyalkenyl, hydroxyalkynyl, carboxyalkyl, carboxyamide, carboxyamidealkyl, amino, aminoalkyl, or a couple that is coupled to saccharide, to a catalytic group, or to a site-directing molecule; and n is an integer values less than or equaled 5.
Patent NZ-333305-A (NZ)
Title: Print head driving for electrocoagulation printing
Inventor: CASTEGNIER ADRIEN
IPC: B41J2/39
Filed: 1998-12-10
Abstract: A printing head system for an electrocoagulation printing apparatus includes a linear array of mutually insulated electrolytically inert electrodes mounted on an electrode carrier, the electrodes being arranged into a plurality of groups 1 to 32 each having a predetermined number (64) of closely spaced electrodes.  A driver circuit 1 to 64 is responsive to a graphical data input signal to cause simultaneous passage of current through at least a major portion of the electrodes in a selected one of the groups, the major portion of electrodes including electrodes that are contiguous with one another.  This enables reduction or elimination of the saw tooth effect prevalent from the prior art electrocoagulation printing electrode driving arrangement.
Patent NZ-335503-A (NZ)
Title: Detecting a call trigger in a telecommunications network without requiring a service platform to remain connected to the call
Inventor: NELSON TRACY LEE
IPC: H04L12/56
Filed: 1997-11-11
Abstract: A system and method to detect a call trigger during a call without requiring a service platform to remain connected to the call includes a first communications device 106 which transmits a call having call signalling and user communications.  A signalling processor 112 receives the call signalling from the first communications device and selects a connection to a second communications device 108.  An interworking unit 14 receives the user communications form the first communications device and converts it from a time division multiplex format to asynchronous transfer mode cells that identify a selected connection to the second communications device.  An interworking unit 114 detects a call trigger in the user communications.  The interworking unit transmits call trigger data to the signalling processor.  The signalling processor processes the call trigger in the user communications.  The interworking unit transmits call trigger data to the signalling processor, which processes the call trigger data and, upon validating the call trigger, instructs the interworking unit to transport the user communications to asynchronous transfer mode cells that identify the selected connection to the third communication device 110 and transports the user communications to the third communications device.
Patent NZ-335956-A (NZ)
Title: Composition comprising a sponge-like structure containing an elastic material such as collagen for use as a base in foodstuffs and pharmaceuticals
Inventor: BEISEL GUNTHER
IPC: A23L33/25
Filed: 1997-05-26
Abstract: The composition for oral ingestion comprises a sponge-like structured material consisting of an elastic material that is insoluble or poorly soluble in water and gastrointestinal fluids is: a) which is deformable, shape-reducible and compressible by chewing and palatine swallowing motion so that it can pass through the oesophagus and b) which, after leaving the oesophagus, is decompressible in water and in gastrointestinal fluids in the stomach in a volume-building manner. The sponge-like structure consists of gas-filled sphere/polyhedron-like cells that are delineated by highly viscous or solid cells webs.
Patent NZ-502836-A (NZ)
Title: Sustained release drug delivery devices
Inventor: CHEN JIANBING
IPC: A61K9/22
Filed: 1998-08-28
Abstract: A device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The device includes an inner core or reservoir comprising the effective agent; a first coating layer, which is permeable to the passage of the effective agent; a second coating layer, which is essentially impermeable to the passage of the effective agent; and a third coating layer, which is permeable to the passage of the effective agent. The first coating layer covers at least a portion of the inner core. The second coating layer covers at least a portion of the first coating layer and inner core; however, at least a small portion of the first coating layer or inner core is not coated with the second coating layer. The second coating layer includes an impermeable film and at least one impermeable disc. The third coating layer essentially completely covers the second coating layer and the uncoated portion of the first coating layer or inner core.
Patent NZ-504311-A (NZ)
Title: Fuel filling point, typically for marine craft, with overflow pocket and fuel drain
Inventor: DAVIES ANTHONY
IPC: B63B25/08
Filed: 2000-05-03
Abstract: Overflow pocket 7 is provided below fuel filling point 1. This has a volume greater than 1 litre and typically approximately 1.7 litres. Overflow conduit 11 allows for drainage of fuel from pocket 7.
Patent NZ-504683-A (NZ)
Title: Amide derivatives and pharmaceutical compositions thereof and their use as matrix metalloprotease inhibitors
Inventor: DICKINSON ROGER PETER
IPC: C07C237/22
Filed: 1998-12-23
Abstract: A compound of formula (I), wherein: R1 is H, OH, alkyl, alkoxy, or alkenyl; R2 is alkyl optionally substituted by fluoro, indolyl, imidazolyl, SO2 alkyl or cycloalkyl, or by an optionally protected OH, SH, CONH2, CO2H, NH2 or NHC(=NH)NH2 group, or R2 is cycloalkyl optionally substituted by C1-6 alkyl, or R2 is optionally substituted benzyl; R3, R5 and R6 are each independently selected from H and F; R4 is CH3, Cl or F; X is HO or HONH; Y is a direct link or O; Z is either a group of formula (a) or (b); Ar is a group of formula (c), (d) or (e). Also described is a pharmaceutical composition comprising the compound of formula (I) in admixture with a compatible adjuvant, diluent or carrier. The compounds of formula (I) are useful for the treatment of conditions mediated by MMPs. Also described are intermediate compounds of formula (II), (III), (IV), (VIIa) and (VIIb).(where all variables are as defined for the compound of formula (I).
Patent NZ-507484-A (NZ)
Title: In vitro assay for growth differentiation factor 9 based on the discovery that GDF-9 binds to granulosa cells found in mammalian ovaries
Inventor: MATZUK MARTIN M
IPC: G01N33/50
Filed: 1999-04-01
Abstract: Described is a method of identifying an agent which alters (inhibits, enhances) activity of GDF-9.  The method involves combining cells having a receptor for GDF-9 and a gene, wherein expression of the gene is regulated by binding of GDF-9 to the receptor; GDF-9; and an agent to be assessed.  The combination produced is maintained under conditions appropriate for binding of GDF-9 to the receptors on the cells.  The extent to which binding of GDF-9 to the receptors on the cells occurs is then determined, wherein binding of GDF-9 to the receptor to a lesser or greater extent in the presence of the agent to be assessed than in its absence, is indicative of an agent which alters GDF-9 activity. The figure depicts a summary of GDF-9 knockout ovary studies.
Patent NZ-507669-A (NZ)
Title: Multiband antenna
Inventor: HAUNBERGER THOMAS
IPC: H01Q5/50
Filed: 2000-03-16
Abstract: A multiband antenna has first and second antenna devices for transmitting or receiving. Each device has a dipole structure and associated dipole halves disposed opposite a base plate or reflector by baluns. The antenna devices are provided with a feed from a common antenna input line and a branch circuit. Frequency selective components are respectively associated with the first and second antenna devices. An electrical length of branch lines between a branch point and a feed point on the associated antenna devices having the dipole structure enables the frequency selective components respectively to reject a frequency band range transmitted via another of the first and second antenna devices
Patent NZ-509213-A (NZ)
Title: Modified glutenin or seed-storage protein by the addition of an exogenous domain
Inventor: APPELS RUDI
IPC: A23L7/117
Filed: 1999-07-12
Abstract: A method for producing a modified glutenin or seed- storage protein, the method comprising adding to a glutenin or seed-storage protein an exogenous amino acid domain capable of binding a lipid, starch or a protein, wherein the modified protein has an ability to incorporate into gluten and wherein the domain is not from said glutenin or seed-storage protein. The exogenous domain is preferably derived from glucoamylase from Aspergillus niger.
Patent NZ-511166-A (NZ)
Title: Genes that increase the production of HMG-CoA reductase inhibitor, ML-236B
Inventor: ONO CHIHO
IPC: C12N15/52
Filed: 2001-04-18
Abstract: A polynucleotide suitable for use in accelerating the biosynthesis of ML-236B, selected from the group consisting of: (a) a polynucleotide encoding a protein having the amino acid sequence of SEQ ID NO 38, or a polynucleotide variant thereof encoding a modified amino acid sequence having at least one deletion, addition, substitution or alteration; and (b) a polynucleotide encoding a protein having the amino acid sequence of SEQ ID NO 42, or a polynucleotide variant thereof encoding a modified amino acid sequence having at least one deletion, addition, substitution or alteration.
Patent NZ-511907-A (NZ)
Title: Squeeze bottle for dispensing a liquid in a metered and substantially germ-free manner
Inventor: SCHILTHUIZEN STEPHANUS FRANSIS
IPC: A01N59/16
Filed: 1999-12-07
Abstract: The invention describes a squeeze bottle for dispensing a liquid, in particular a liquid medicament, in a metered and substantially germ-free manner, at least comprising: a storage chamber for accommodating the liquid, a metering chamber with a variable volume for dispending from this chamber, under reduction of volume of the chamber, a measured volume of liquid, restoring means for returning the metering chamber to its original state after a volume of liquid has been dispensed, an inlet for placing the metering chamber in communication with the storage chamber by mediation of a flow restrictor, which flow restrictor counteracts flow from the metering chamber to the storage chamber substantially completely when the pressure in the storage chamber is increased, counteracts flow between the storage chamber and the metering chamber substantially completely and , when the increase pressure in the storage chamber is removed, allows flow from the storage chamber into the metering chamber, at least one outflow opening for placing the interior of the metering chamber in communication with the environment, the outflow opening comprising a non-return valve, actuating means can be actuated by squeezing the bottle, means for ventilating the squeeze bottle
Patent NZ-515173-A (NZ)
Title: Treatment of hypersensitivity reaction disorders
Inventor: SAUDER DANIEL
IPC: A61K41/00
Filed: 2000-04-19
Abstract: Use in the manufacture of a medicament for the treatment or prophylaxis of T-cell mediated delayed type hypersensitivity conditions in a mammalian patient, of an aliquot of modified mammalian blood for administration to the patient, the blood aliquot having been modified extracorporeally by simultaneous or sequential exposure to the stress of an oxidative environment and the stress of UV radiation.
Patent NZ-516962-A (NZ)
Title: Stoma opening forming apparatus
Inventor: FORSELL PETER
IPC: A61B19/00
Filed: 2000-08-01
Abstract: An  apparatus for forming a stoma opening is used  for the  treatment  of  morbid obesity or heartburn  and  reflux disease. An implanted elongated restriction member  (12)  of the  apparatus  is  formed  in a substantially  closed  loop around   a   human's  stomach  or  esophagus  to  define   a restriction  opening  (16), whereby  a  corresponding  stoma opening  is formed in the stomach or esophagus. The size  of the  restriction  opening  is  adjustable  by  an  implanted adjustment  device.  A control device (22)  is  utilized  to control the adjustment device, in order to either reduce  or enlarge  the  size of the restriction opening. Nausea  in  a treated  obese  human  can  be  minimized  or  substantially eliminated  as  a  result of the control device  controlling the  adjustment  device  to  keep  the  restriction  opening substantially  fully open between meals (such  as  at  night when  the  human  is sleeping). A sensor  (23),  such  as  a pressure or position sensor, is surgically implanted in  the human's  body  so  that the sensor may  either  directly  or indirectly sense a physical parameter of the human, such  as the  pressure in the stomach or the human's orientation with respect to the horizontal. If in response to sensing by  the sensor  it  is  determined  by the  control  device  that  a significant  change in the physical parameter has  occurred, then  the  control device controls the adjustment device  to either  reduce  or  enlarge  the  size  of  the  restriction opening.
Patent NZ-518823-A (NZ)
Title: Biodegradable cross-linking agents and cross-linked network polymers formed therewith
Inventor: KISER PATRICK F
IPC: C07C233/20
Filed: 2000-06-22
Abstract: Biodegradable cross-linkers having a polyacid core with at least two acidic groups covalently connected to reactive groups usable to cross-link polymer filaments are disclosed, wherein between at least one reactive group and an acidic group of the polyacid is a biodegradable region that preferably consists of a hydroxyalkyl acid ester sequence having 1, 2, 3, 4, 5 or 6 hydroxyalkyl acid ester groups. The polyacid may be attached to a water soluble region that is attached to the biodegradable region having attached reactive groups. The hydroxyalkyl acid ester group is preferably a lactate or glycolate. Polyacids include diacids, triacids, tetraacids and pentaacids, and the reactive group may contain a carbon-carbon double bond. A network of cross-linked polymer filaments having a defined biodegradation rate can be formed using the cross-linkers. The network may contain biologically active molecules, and can be in the form of a microparticle or nanoparticle, or hydrogel. The polymer filaments may be preformed polymer filaments of polynucleic acids, polypeptides, proteins or carbohydrates. The cross-linkers may be copolymerized with charged monomers such as acrylic monomers containing charged groups. Applications of the cross-linkers and network include controlled release of drugs and cosmetics, tissue engineering, wound healing, hazardous waste remediation, metal chelation, swellable devices for absorbing liquids and prevention of surgical adhesions.
Patent NZ-519174-A (NZ)
Title: Collar assembly for watercraft
Inventor: HEMPHILL DOUGLAS H
IPC: B63B7/08
Filed: 2000-11-30
Abstract: Collar assemblies for use with watercraft including rigid-hulled boats are disclosed. Collars of the assemblies may surround or envelope all or most of the perimeters of boats and provide increased buoyancy at least at their sterns. The collars typically are split, rather than continuous, both to facilitate installation and to reduce risk of damage during the installation process
Patent NZ-519933-A (NZ)
Title: Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments for regulating the ORL1 (opioid-receptor-like) receptor of the nociceptin/orphanin FQ ligand-OPL1 receptor system
Inventor: SUNDERMANN BERND
IPC: A61K31/137
Filed: 2000-12-20
Abstract: Use of substituted 4-amino-1-phenylbutan-2-ol compounds in the form of their racemates, enantiomers, diastereomers or corresponding bases or corresponding salts of physiologically acceptable acids as regulators for the nociceptin/orphanin-FQ ligand ORL1 receptor system and for the production of medicaments are disclosed.
Patent NZ-521672-A (NZ)
Title: Blow-off Valve
Inventor: ADRIAN JOHN
IPC: F02B37/16
Filed: 2002-09-30
Abstract: A blow-off valve apparatus (54) for use in an internal combustion engine (10) having a compressor (35) for supercharging the engine, the compressor including a compressor inlet (48) for receiving gas to the compressor and a compressor outlet (38) for expelling compressed gas from the compressor. The apparatus includes an apparatus inlet (52) configured for connection in fluid flow communication to the compressor outlet for receiving expelled compressed gas from the compressor; a first apparatus outlet (58) configured to exhaust to atmosphere a first portion of gas received by the apparatus inlet; variable first control means configured for varying the volume flow rate of exhaustion of the first portion through the first apparatus outlet; and a second apparatus outlet (62) configured for being connected in fluid flow communication to the compressor inlet and for directing a second portion of gas received by the apparatus inlet, to enable the second portion to be returned to the compressor inlet when the second apparatus outlet is connected to the compressor inlet.
Patent NZ-522733-A (NZ)
Title: Non-antibacterial tetracycline as anti-fungal agents
Inventor: LIU YU
IPC: A61K31/65
Filed: 2001-06-01
Abstract: The specification relates to a method of inhibiting growth of a fungus in a non-human mammal. The method involves contacting the fungus with an effective amount of chemically-modified tetracycline compound (CMT) selected from the group consisting of CMT-3, CMT-4, CMT-7, CMT-8, CMT-315 and combinations of these. The fungus may be: Cryptococcus species, Candida albicans, Rhizopus species, Aspergillus fumigatus, Penicillium species, Absidia species, Scedosporium apiospermum, Phialophora verrucosa, Cunninghamella species, Tricothecium species, Ulocladium species or Fonsecae species. The chemically-modified tetracycline compound can be used for inhibiting the growth of a fungus in a mammal when prepared as a medicament and maybe used topically, by systemic administration or as a mouthwash.
Patent NZ-524597-A (NZ)
Title: Low sidestream smoke cigarette with non-combustible treatment material
Inventor: SNAIDR STANISLAV M
IPC: A24D1/02
Filed: 2001-09-18
Abstract: Disclosed is a low sidestream smoke cigarette comprising a tobacco rod and a non-combustible treatment material for the rod, wherein the treatment material has a porosity less than 200 Coresta units, and a sidestream smoke treatment composition comprising, in combination, an oxygen storage and donor metal oxide oxidation catalyst and an essentially non-combustible finely divided porous particulate adjunct for the catalyst. The adjunct may comprise such materials as, zirconium fibres, zirconium/cerium fibres, ceramic fibres, carbon fibres, zirconium oxides, titanium oxides, cerium oxides and zeolites.